Camurus, a Swedish research-based pharmaceutical company, announced that the European Commission (EC) has approved weekly and monthly Buvidal (prolonged release buprenorphine) for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results